mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.1 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.1 |